Literature DB >> 31206229

Analysis of Site-Specific Phosphorylation of PTEN by Using Enzyme-Catalyzed Expressed Protein Ligation.

Samuel H Henager1, Stephanie Henriquez1, Daniel R Dempsey2, Philip A Cole2.   

Abstract

The activity and localization of PTEN, a tumor suppressor lipid phosphatase that converts the phospholipid PIP3 to PIP2, is governed in part by phosphorylation on a cluster of four Ser and Thr residues near the C terminus. Prior enzymatic characterization of the four monophosphorylated (1p) PTENs by using classical expressed protein ligation (EPL) was complicated by the inclusion of a non-native Cys at the ligation junction (aa379), which may alter the properties of the semisynthetic protein. Here, we apply subtiligase-mediated EPL to create wt 1p-PTENs. These PTENs are more autoinhibited than previously appreciated, consistent with the role of Tyr379 in driving autoinhibition. Alkaline phosphatase sensitivity analysis revealed that these autoinhibited 1p conformations are kinetically labile. In contrast to the Cys mutant 1p-PTENs, which are poorly recognized by an anti-phospho-PTEN antibody, three of the four wt 1p-PTENs are recognized by a commonly used anti-phospho-PTEN antibody.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  PTEN; enzyme kinetics; phosphatases; phosphorylation; semisynthesis

Mesh:

Substances:

Year:  2019        PMID: 31206229      PMCID: PMC7012368          DOI: 10.1002/cbic.201900316

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  18 in total

1.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

2.  Molecular Features of Phosphatase and Tensin Homolog (PTEN) Regulation by C-terminal Phosphorylation.

Authors:  Zan Chen; Daniel R Dempsey; Stefani N Thomas; Dawn Hayward; David M Bolduc; Philip A Cole
Journal:  J Biol Chem       Date:  2016-05-11       Impact factor: 5.157

3.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.

Authors:  D Liaw; D J Marsh; J Li; P L Dahia; S I Wang; Z Zheng; S Bose; K M Call; H C Tsou; M Peacocke; C Eng; R Parsons
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

4.  Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.

Authors:  J O Lee; H Yang; M M Georgescu; A Di Cristofano; T Maehama; Y Shi; J E Dixon; P Pandolfi; N P Pavletich
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

5.  Direct identification of PTEN phosphorylation sites.

Authors:  Susan J Miller; David Y Lou; David C Seldin; William S Lane; Benjamin G Neel
Journal:  FEBS Lett       Date:  2002-09-25       Impact factor: 4.124

6.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

7.  Synthesis of proteins by native chemical ligation.

Authors:  P E Dawson; T W Muir; I Clark-Lewis; S B Kent
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

8.  A designed peptide ligase for total synthesis of ribonuclease A with unnatural catalytic residues.

Authors:  D Y Jackson; J Burnier; C Quan; M Stanley; J Tom; J A Wells
Journal:  Science       Date:  1994-10-14       Impact factor: 47.728

9.  Inorganic and organic phosphate measurements in the nanomolar range.

Authors:  P P Van Veldhoven; G P Mannaerts
Journal:  Anal Biochem       Date:  1987-02-15       Impact factor: 3.365

10.  Enzyme-catalyzed expressed protein ligation.

Authors:  Samuel H Henager; Nam Chu; Zan Chen; David Bolduc; Daniel R Dempsey; Yousang Hwang; James Wells; Philip A Cole
Journal:  Nat Methods       Date:  2016-09-26       Impact factor: 28.547

View more
  6 in total

Review 1.  Chemoenzymatic Semisynthesis of Proteins.

Authors:  Robert E Thompson; Tom W Muir
Journal:  Chem Rev       Date:  2019-11-27       Impact factor: 60.622

2.  Selective protein N-terminal labeling with N-hydroxysuccinimide esters.

Authors:  Hanjie Jiang; Gabriel D D'Agostino; Philip A Cole; Daniel R Dempsey
Journal:  Methods Enzymol       Date:  2020-04-28       Impact factor: 1.600

3.  Structural and Dynamic Effects of PTEN C-Terminal Tail Phosphorylation.

Authors:  Iris N Smith; Jennifer E Dawson; James Krieger; Stetson Thacker; Ivet Bahar; Charis Eng
Journal:  J Chem Inf Model       Date:  2022-08-24       Impact factor: 6.162

4.  The structural basis of PTEN regulation by multi-site phosphorylation.

Authors:  Daniel R Dempsey; Thibault Viennet; Reina Iwase; Eunyoung Park; Stephanie Henriquez; Zan Chen; Jeliazko R Jeliazkov; Brad A Palanski; Kim L Phan; Paul Coote; Jeffrey J Gray; Michael J Eck; Sandra B Gabelli; Haribabu Arthanari; Philip A Cole
Journal:  Nat Struct Mol Biol       Date:  2021-10-08       Impact factor: 18.361

5.  Fluctuations in AKT and PTEN Activity Are Linked by the E3 Ubiquitin Ligase cCBL.

Authors:  Manuel Olazábal-Morán; Miriam Sánchez-Ortega; Laura Martínez-Muñoz; Carmen Hernández; Manuel S Rodríguez; Mario Mellado; Ana C Carrera
Journal:  Cells       Date:  2021-10-20       Impact factor: 6.600

Review 6.  Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression.

Authors:  Chen Xue; Ganglei Li; Juan Lu; Lanjuan Li
Journal:  Signal Transduct Target Ther       Date:  2021-11-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.